TITLE

IS PURDUE the nexyt big pharma company?

AUTHOR(S)
Wall, J. K.
PUB. DATE
November 2013
SOURCE
Indianapolis Business Journal;11/4/2013, Vol. 34 Issue 36, p17A
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article features Indiana-based pharmaceutical company Purdue and mentions the innovation at its drug discovery equipment. It discusses the Purdue Drug Discovery Initiative and notes the effort of the company in conducting clinical trials for the discovery and manufacture of drugs. It also tackles the establishment of a five-person advisory committee,
ACCESSION #
91811065

 

Related Articles

  • And Then...Oracle Bought Phase.  // Applied Clinical Trials;May2010, Vol. 19 Issue 5, p12 

    The article reports on the move of Oracle Health Sciences to purchase clinical software Phase Forward Inc. to show that it recognizes the synergies between clinical research and health care in the U.S. It cites that analysts have considered the integration of electronic health record (EHR) and...

  • Other News To Note.  // BioWorld International;10/26/2011, Vol. 16 Issue 43, p3 

    The article offers news briefs on drug manufacturing. A Phase III trial of laquinimod by Sweden's Active Biotech AB and Jerusalem's Teva Pharmaceutical Industries Ltd. showed that it significantly reduced the relapse of multiple sclerosis. Danish drug manufacturer Affitech received 2.5 million...

  • International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; ICH M2 EWG, Electronic Common Technical Document. Shravya, K.; Swathi, P.; Snigdha, B.; Rashtrapal, D.; Chaitanya Prasad, K.; Suthakaran, R. // International Journal of Pharmaceutical Sciences Review & Resear;Sep/Oct2014, Vol. 28 Issue 1, p152 

    Demonstration of safety and efficacy of the drug product for use in humans is essential before the drug product can be approved for import or manufacturing of new drug by the applicant by regulatory authority in any country. Once preclinical and clinical trial data have been collected, a New...

  • Discovery Outsourcing Report. Aldrich, Steven // Contract Pharma;Sep2012, Vol. 14 Issue 7, p120 

    The article reports on the involvement in outsourcing by pharmaceutical companies in the BRIC countries. It highlights the services that are being outsourced including clinical trial management, manufacturing, and drug discovery. It highlights the process of drug discovery including target...

  • Securing the Clinical Supply Chain by Increasing Information Flow. Santa Maria, Vince // Pharmaceutical Processing;Oct2015, Vol. 30 Issue 8, p14 

    The article discusses the importance of well-managed supply chains in the success of pharmaceutical production. Topics covered include the complexity in balancing clinical supplies with patient administration, the decoupling of information to sponsors and investigators as part of strategic...

  • Early Development GMPs for Drug-Product Manufacturing of Small Molecules. Creekmore, Richard; Dokou, Eleni; Eylath, Amnon; Joiner, Dennis; Lovdahl, Michael; Pellett, Jackson; Schmitt, Eric; Skoug, John w. // Pharmaceutical Technology Europe;Sep2012, Vol. 24 Issue 9, p71 

    The article focuses on the common practices in the pharmaceutical industry in the employment of current good manufacturing practices (GMPs) in early development. It suggests that companies should use a risk-based approach to help in decision making in drug development and manufacturing. It says...

  • THE GLOBAL REPORT.  // Applied Clinical Trials;Jan2007, Vol. 16 Issue 1, p22 

    The article presents news items concerning the global clinical trials industry as of January 2007. The Philippines' Bureau of Food and Drugs has approved Merck Sharp & Dohme's cervical cancer vaccine Gardasil. The European Medicine Agency has unveiled EudraPharm, a public database where...

  • Institutional review boards - a mixed blessing. Saleem, Taimur; Khalid, Umair // International Archives of Medicine;2011, Vol. 4 Issue 1, p19 

    Institutional Review Boards (IRBs) are an important checkpoint for all types of research in medicine. Although these bodies originated primarily in the developed world, they have special contemporary consideration in the context of developing countries due to the large number of clinical trials...

  • From Tokyo with love. Whitworth, Rich // Pharmaceutical Technology Europe;Apr2011, Vol. 23 Issue 4, p6 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including a story from Patricia Van Arnum, special reports from pharmaceutical industry around the world, and an article on the industry's regulatory tale from readers.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics